flow study semaglutide FLOW- the Visual Abstract — NephJC Media Centre | EASD
Description
Competition Landscape 18.1
Conclusion GLP-1 therapy represents a significant advancement in weight management, offering both metabolic and appetite-regulating benefits
Note that upper arm injections are generally recommended to be administered by a caregiver, per manufacturer instructions for use
If you qualify (which is based on metabolic testing ), you can choose between the GLP-1 Rx plan, or the branded plan
Not for human consumption, medical, veterinary, or diagnostic use
The numbers tell an impressive story patients lost 14.9% of their body weight compared to just 2.4% in the placebo group over 68 weeks
